Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Resistance to dieldrin (RDL) GABA-gated chloride channel is a critical inhibitory neurotransmitter receptor found in the central nervous system of insects and acarines, such as ticks and mites [PubMed: 23103374]. As a member of the Cys-loop ligand-gated ion channel superfamily, it mediates fast inhibitory synaptic transmission by allowing chloride ions to flow into neurons upon the binding of gamma-aminobutyric acid (GABA) [UniProt: P25123]. This influx causes membrane hyperpolarization, effectively dampening neuronal excitability [PubMed: 28445611]. These channels are primary targets for several major classes of insecticides and acaricides because they exhibit significant structural and pharmacological differences from mammalian GABA receptors, ensuring high selective toxicity [PubMed: 24814634]. Drugs like fipronil and the isoxazoline class (e.g., fluralaner) act as non-competitive antagonists that bind within the channel pore to block chloride conductance [PubMed: 25239189]. This blockage results in uncontrolled nervous system activity, convulsions, and the eventual death of the target organism [PubMed: 24814634]. Resistance to these chemicals is frequently linked to specific point mutations in the RDL gene, such as the substitution of alanine at position 302, which reduces drug binding affinity [PubMed: 11113255].
Non-competitive antagonism of the chloride channel pore, which prevents the influx of chloride ions into neurons, leading to hyperexcitation, paralysis, and death of the parasite.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Resistance to dieldrin (RDL) GABA-gated chloride channel (GABACl).